Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia
· Delayed Price · Currency is SAR 158.20
-1.60 (-1.00%)
Mar 6, 2025, 3:16 PM AST
TADAWUL:4015 Revenue
Jamjoom Pharmaceuticals Factory Company had revenue of 327.58M SAR in the quarter ending September 30, 2024, with 11.95% growth. This brings the company's revenue in the last twelve months to 1.27B, up 16.44% year-over-year. In the year 2023, Jamjoom Pharmaceuticals Factory Company had annual revenue of 1.10B with 20.09% growth.
Revenue (ttm)
1.27B
Revenue Growth
+16.44%
P/S Ratio
8.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.07B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Sulaiman Al Habib Medical Services Group Company | 11.20B |
| Mouwasat Medical Services Company | 2.90B |
| Nahdi Medical Company | 9.30B |
| Dallah Healthcare Company | 3.20B |
| National Medical Care Company | 1.29B |
| Middle East Healthcare Company | 2.88B |
| Almoosa Health Company | 1.20B |
| Al Hammadi Holding Company | 1.15B |